Biomerica (BMRA) Accumulated Expenses (2011 - 2026)

Biomerica (BMRA) has 16 years of Accumulated Expenses data on file, last reported at $608000.0 in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 0.65% year-over-year to $608000.0; the trailing twelve-month figure through Feb 2026 stood at $608000.0 (down 0.65% YoY), and the FY2025 full-year result was $655000.0, up 13.32% from the prior year.
• Accumulated Expenses rose to $608000.0 in Q1 2026, from $545000.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $702000.0 in Q1 2024 to a low of $236000.0 in Q2 2022.
• A 5-year average of $588286.4 and a median of $601000.0 in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses tumbled 39.32% in 2022 and jumped 132.2% in 2023, its largest moves.
• Tracing BMRA's Accumulated Expenses over 5 years: stood at $697179.0 in 2022, then fell by 4.19% to $668000.0 in 2023, then dropped by 10.03% to $601000.0 in 2024, then dropped by 9.32% to $545000.0 in 2025, then gained by 11.56% to $608000.0 in 2026.
• Business Quant data shows BMRA's Accumulated Expenses at $608000.0 in Q1 2026, $545000.0 in Q4 2025, and $591000.0 in Q3 2025.